Stay updated on AK104 Plus Anlotinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the AK104 Plus Anlotinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AK104 Plus Anlotinib in NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Recruitment is now closed for participants. A new revision (v3.6.0) has been added and the previous revision (v3.5.5) removed.
    Difference
    0.4%
    Check dated 2026-06-12T11:41:07.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The Record History adds a new release entry showing Revision: v3.5.5, replacing the previous Revision: v3.5.4. This reflects an administrative update to the page's versioning and release notes.
    Difference
    0.1%
    Check dated 2026-06-05T08:10:53.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    There are no additions or deletions recorded for this study history in the provided data.
    Difference
    0.1%
    Check dated 2026-05-21T22:38:36.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.5.4' was added to the Record History, indicating the study record has been updated to a newer version in the history log.
    Difference
    0.2%
    Check dated 2026-05-14T22:17:04.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    A new revision entry v3.5.3 was added to the Record History, and the previous revision v3.5.2 was removed.
    Difference
    0.1%
    Check dated 2026-04-30T15:37:10.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    A new revision entry v3.5.2 was added to the version history, and the entry for v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-16T10:12:53.000Z thumbnail image

Stay in the know with updates to AK104 Plus Anlotinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AK104 Plus Anlotinib in NSCLC Clinical Trial page.